Gul Jana Saeed

Gul Jana Saeed

Auto-generated profile, based on publicly available information

Gul Jana Saeed

Affiliation Center for Sleep and Cardiovascular Outcomes Research, University of Pittsburgh, Pittsburgh, PA, United States of America

Research Focus & Metrics

Academic Career Length

5Years (2022-Present)

(Calculated once Scilit publication data is synced: current year − year of first publication + 1)

Representative Publications

View All Publications
1 December 2024 in Radiology
Verified
Journal Article
Closed access
SMSaloni Mehta
Saloni Mehta
HPHannah Peterson
Hannah Peterson
JYJean Ye
Jean Ye
AIAhmad Ibrahim
Ahmad Ibrahim
GSGul Saeed
Gul Saeed
DSDustin Scheinost
Dustin Scheinost
T1-weighted MRI and resting-state functional MRI revealed structural and functional brain alterations in opioid receptor–dense regions, such as the thalamus, right medial temporal lobe, cerebellum, and brainstem, in individuals with opioid use disorder compared with healthy controls.

6 April 2022 in PLOS ONE
Verified
Journal Article
Open access
PDF file
EAEhimen C. Aneni
Ehimen C. Aneni
GSGul Jana Saeed
Gul Jana Saeed
MBMarcio Sommer Bittencourt
Marcio Sommer Bittencourt
MCMiguel Cainzos-Achirica
Miguel Cainzos-Achirica
COChukwuemeka U. Osondu
Chukwuemeka U. Osondu
KNKhurram Nasir
Khurram Nasir
Background: There is limited knowledge about the risk of non-alcoholic fatty liver disease (NAFLD) associated with cardiometabolic disorders in lean persons. This study examines the contribution of cardiometabolic disorders to NAFLD risk among lean individuals and compares to non-lean individuals.Methods: We analyzed longitudinal data from 6,513 participants of a yearly voluntary routine health testing conducted at the Hospital Israelita Albert Einstein, Brazil. NAFLD was defined as hepatic ultrasound diagnosed fatty liver in individuals scoring below 8 on the alcohol use disorders identification test. Our main exposure variables were elevated blood glucose, elevated blood pressure (BP), presence of atherogenic dyslipidemia (AD, defined as the combination of elevated triglycerides and low HDL cholesterol) and physical inactivity (<150 minutes/week of moderate activity). We further assessed the risk of NAFLD with elevations in waist circumference and high sensitivity C-reactive protein (HsCRP).Results: Over 15,580 person-years (PY) of follow-up, the incidence rate of NAFLD was 7.7 per 100 PY. In multivariate analysis adjusting for likely confounders, AD was associated with a 72% greater risk of NAFLD (IRR: 1.72 [95% CI:1.32–2.23]). Elevated blood glucose (IRR: 1.71 [95%CI: 1.29–2.28]) and physical inactivity (IRR: 1.46 [95%CI: 1.28–1.66]) were also independently associated with increased risk of NAFLD. In lean individuals, AD, elevated blood glucose and elevated BP were significantly associated with NAFLD although for elevated blood glucose, statistical significance was lost after adjusting for possible confounders. Physical inactivity and elevations in HsCRP were not associated with the risk of NAFLD in lean individuals only. Among lean (and non-lean) individuals, there was an independent association between progressively increasing waist circumference and NAFLD.Conclusion: Cardiometabolic risk factors are independently associated with NAFLD. However, there are significant differences in the metabolic risk predictors of NAFLD between lean and non-lean individuals. Personalized cardiovascular disease risk stratification and appropriate preventive measures should be considered in both lean and non-lean individuals to prevent the development of NAFLD.